2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

Research output

Research output per year 2017 2017 2017

• 184 Citations
• 1 Article

Research output per year

Research output per year

Search results

• 2017

  Corrigendum to: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia [Eur Heart J (2017)

  Landmesser, U., Chapman, M. J., Stock, J. K., Amarenco, P., Belch, J., Borén, J., Farnier, M., Ference, B. A., Gielen, S., Graham, I., Grobbee, D. E., Hovingh, G. K., Luscher, T. F., Piepoli, M., Ray, K. K., Stroes, E. S., Wiklund, O., Windecker, S., Zamorano, J. L. & Pinto, F. & 3 others, Tokgozoglu, L., Bax, J. J. & Catapano, A. L., 24 Nov 2017, In: European Heart Journal. p. 1-1 1 p., ehx648.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  2 Citations (Scopus)